Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014


ELA: Advances in Cellular Assays & Cell Culture

14 May 2014 - 15 May 2014 - Barcelona, Spain



Bookmark and Share


SELECTBIO's Advances in Cellular Assays & Cell Culture conference will focus primarily on bio-processing technologies as well as applications.  Both up-stream and down-stream bio-processing are addressed and our focus in this track is to highlight technology trends, end-user application segments, and opportunities in the application of new approaches for addressing bottlenecks in bio-processing which currently exist. SELECTBIO highlights emerging companies in this conference track and we encourage submissions from start-up and new technology entrants.
 The second part of the Advances in Cellular Assays & Cell Culture conference track will focus upon new methodologies for cellular capture including emerging trends in flow cytometry—we seek to highlight in this segment the new instrumentation for flow cytometry and novel application areas.  Here also, we encourage submissions from start-up companies and new technology providers.

Together, this conference track seeks to bring together end-users as well as technology developers to address emerging applications in cellular analysis and bioprocessing deployment.

Running alongside the Advances in Cellular Assays & Cell Culture conference will be the ELA exhibition, covering the latest technological advances and associated services from leading solution providers within this field. Registered delegates will also have access to the following co-located conference tracks, ensuring a cost effective trip: Advances in NGS & Big Data, High Content Analysis, Advances in Automation & Robotics and Advances in qPCR & dPCR.

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!
Poster Submission Deadline: 02 May 2014




Further information
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!